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Abstract
Background: Lung cancer is a leading cause of cancer-related mortality in Sri Lanka and throughout the world.
The latest staging system for lung cancer is the tumor node metastasis (TNM) 7
th edition in which there are major
changes to the previous version. The objective of our study was to find out the implications of TNM7
th edition on
lung cancer staging in a resource limited setting, and to compare it with the previous TNM 6
th edition.
Methods: Patients with histologically proven lung cancer consecutively presented to respiratory unit of Teaching
Hospital Kandy, Sri Lanka were recruited to the study over a period of one year from April 2010 to March 2011.
They were staged using CT, ultrasound scan of abdomen, bronchoscopy and CT spine and brain when necessary.
Staging was done using TNM 7 as well as TNM6. Surgical or non-surgical treatment arms were decided on staging
and the number of patients in each treatment arm was compared between the two staging systems.
Results: Out of 62 patients, thirty four patients (54%) had metastatic disease and 19 (30%) of them had pleural
effusions (M1a), while 15 (24%) had distant metastasis (M1b). When compared to TNM6 there was no difference in
the number of patients in T1 category, but the number in T2 was higher in TNM7 (25 Vs 20). Similarly the number
in T3 group was higher in TNM7 (11 Vs 5) and the number in M category was doubled (34 Vs 17 [Chi-6.46, p =
0.011]) compared to TNM 6. The number of patients suitable for surgery were 17(27.5%) in TNM 7 and 18(29%)
[Chi-0.02, p = 0.88] in TNM6.
Conclusions: This study shows that a significant proportion of patients were having advanced disease with distant
metastasis on presentation. The number of patients falling to stage IV is significantly higher when staged with
TNM7 but there was no significant difference in the number of patients undergoing surgery when TNM 7 was
used compared to TNM6.
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Background
Lung cancer is a leading cause of cancer-related mortal-
ity in Sri Lanka and throughout the world. Accurate sta-
ging of lung cancer is very important to offer
appropriate treatment [1]. Latest staging system for lung
cancer is the tumor node metastasis (TNM) 7
th edition
published by the International Union Against Cancer
(UICC) and American Joint Committee on Cancer using
the data base of International Association for the Study
of Lung Cancer (IASLC) in December 2009 [2]. This
new edition formulated on data from 68463 patients
from 20 countries spanning Asia, Australia, Europe and
North America, is based on survival data and therefore
reflects the prognosis better than the previous 6
th edi-
tion of TNM [2,3]. One of the changes in the TNM 7
th
edition is the classification of pleural effusion as a
metastasis (M1a) descriptor, which was classified as a
T4 descriptor in the previous version [3]. This shift
could result in a major change in group staging as it
would group these patients to stage four. As a signifi-
cant proportion of patients have pleural effusions it is
expected that the patients falling in to stage four will go
up with the latest staging system.
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arms are decided by several criteria, and the stage of the
cancer is an important criterion in deciding the treat-
ment option. Therefore changes in the new classification
and staging would alter the number of patients under-
going surgical treatment as well as non-surgical treat-
ment. This will have a great clinical effect in the
management of patients with lung cancer. However
accurate lung cancer staging in a resource limited set-
ting like ours will be difficult due to lack of facilities like
PET/CT, MRI and mediastinoscopy.
The objective of our study was to find out the impli-
cations of TNM7
th e d i t i o no nl u n gc a n c e rs t a g i n gi na
resource limited setting, and to compare it with the pre-
vious TNM 6
th edition.
Results
There were 62 patients with histologically confirmed
lung carcinoma. Out of them 50 (81%) were males and
12 (19%) were females. Forty two (84%) males and 1
(8%) female were smokers [Chi-113.1,p <0 . 0 0 0 1 ] .M e a n
age of males was 61 (range 34 to 84) and females was
57 (range 38 to 79) years. Four (8.0%) out of 50 males
and 5 (41.6%) out of 12 females were below the age of
50 [Chi-6.33, p = 0.011].
Age specific incidence of lung cancer in males and
females is shown in Figure 1.
The commenest histological type was squamous cell
carcinoma reaching 36 (58%) (males 32, females 4). Fif-
teen (24%)(males 9, females 6) were having adenocarci-
noma,5 (8%) small cell carcinomas(all were males) and 6
(9%) (males 4, females 2) patients were having other
types of carcinomas.
Chest imaging revealed bilateral lesions in 4 (6.5%)
patients while 30 (48.4%) had right sided lesions and 28
(45.1%) had left sided lesions. Table 1 shows the distri-
bution of lesions on chest imaging.
Masses, effusions, collapsed areas, multiple nodules
and cavities were the types of lesions found on chest
imaging. Some patients had a combination of the
lesions. Twenty five patients (42%) had a lung mass on
imaging, 10 (17.7%) had a mass with effusion, and 9
(16%) had a mass with collapse of a lobe. Six (13%) pre-
sented with effusion only while 3 (6.3%) had multiple
nodules. Collapse of a lobe was the finding in 2 (3.2%)
and 1 patient (1.6%) had a cavity on chest imaging.
The commenest bronchoscopic lesion was the pre-
sence of a growth on a lobar bronchus (43%). Figure 2
shows the bronchoscopic appearance in patients with
lung cancer.
Thirty four patients (54%) had metastatic disease on
a d m i s s i o n .O u to ft h e m1 9( 3 0 % )h a dp l e u r a le f f u s i o n s
(M1a), while 15 (24%) had distant metastasis (M1b).
Out of distant metastasis 7(47%) had multiple metasta-
sis. Three (20%) had liver metastasis, 2 (13%) adrenal, 2
(13%) brain and 1(7%) had bone metastasis.
TNM staging was done using TNM 7
th as well as
TNM 6
th and the number of patients in each category is
shown in Table 2.
T h en u m b e ro fp a t i e n t si nT 3g r o u pw a sh i g h e ri n
TNM7 (11 Vs 5) and the number in M category was
doubled (34 Vs 17, [Chi-6.46, p = 0.011]) compared to
TNM 6.
Figure 1 Age specific incidence of lung cancer in males and
females.
Table 1 Distribution of lesions on chest imaging
Site of
lesion
Total* hilar Upper
lobe
Middle lobe
/Lingula
Lower
lobe
Pleural
effusion
Right 30 7 12 3 3 10
left 28 10 7 1 6 9
*Four patients had bilateral lesions
Figure 2 Bronchoscopic appearance in patients with lung
cancer.
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shown in Table 3.
The number of patients in stage IIIB were lower in
TNM7 (10 Vs 25) while the number in stage IV was
higher (35 Vs 19) [Chi-9.75, p0.002].
When TNM 7
th was compared with TNM 6
th,2 1
(33.8%) patients had a change in the TNM classification
while 20 (32.2%) patients had a change in the group sta-
ging. Out of them 17(27.5%) patients were placed to a
more advanced stage and 3 (4.8%) patients were staged
to a lesser advanced stage by the new system.
Management plan according to the stage is shown in
Table 4.
The number of patients suitable for surgery were 17
(27.5%) in TNM 7 and 18(29%) [Chi-0.02, p = 0.88] in
TNM6.
Discussion
As with previous similar studies [1] this study confirms
the male predominance in lung cancer incidence which
could be due to high prevalence of active smoking
among males. According to Cancer Registry of Sri
Lanka, adenocarcinomas are commoner 69% than squa-
mous carcinomas 28% [4]. However in our series squa-
mous carcinomas were common 58% and
adenocarcinoma contributed only to 24% (Chi-29.54, p
< 0.0001). The discrepancy could be due to the small
sample size in this series. Not all patients are referred to
respiratory unit for diagnosis, and some patients are
diagnosed in other units like medical, surgical and thor-
acic surgical unit therefore causing a selection bias
which could be another reason for the discrepancy.
However this could not have caused a significant impact
on staging as, apart from small cell carcinomas which
are aggressive other non-small cell carcinomas behave
similarly.
An interesting finding is that the age specific inci-
dence between males and females differ significantly. In
males the peak incidence was between 60 to 69 age
group, which was parallel to the national incidence data.
The highest number in female group was between 40 to
49 age group. According to national data, peak inci-
dence in females occurred in 50 to 54 age group. The
proportion of patients below 50 years of age is higher in
females. Compared to UK [5], females with lung cancer
in Sri Lanka were younger according to national statis-
tics, which is further strengthened by our data. Whether
this is connected with the exposure to fire wood smoke
during cooking, needs to be investigated.
The presence of distant metastasis at presentation was
higher (24%) compared to the western figures (21%) [6].
This could have been due to the late presentation of
patients in our country. The number of patients who
had brain secondaries (13%) was less compared to the
s t u d yd o n eb yL e s l e ie ta l( 1 9 % )b u tp r e s e n c eo fm u l t i -
ple secondaries (47%) was higher compared to the same
study (33%) [6].
Usually about 15% of patients with lung cancer will
have pleural effusions [7], but in our study it was very
high reaching 56% [Chi-34.9,p < 0.001]. This was a
major finding in our study which again provides evi-
dence to the late presentation of patients.
W h e nt h et u m o r sw e r es t a g e du s i n gT N M7a n d
TNM 6 separately it was evident that there was no dif-
ference in the number of patients in T1 category, but
the number in T3 group was higher in TNM7 (11) than
with TNM 6 (5). This is due to the reclassification of
tumors larger than 7 cm as T3 and change in classifica-
tion of separate tumor nodule(s) in the same lobe from
T4 descriptor to T3 in the recent staging system (3).
Reclassification of pleural effusions as M1a has several
impacts on the T descriptor in new system. Tumors
that could be classified as T2 according to size fell into
T 4g r o u pi nT N M 6 .I nn e ws y s t e mt h e yw e r er e c l a s s i -
fied as T2M1a. Similarly tumors that fit into T3 by size
fell into T4 in TNM6 due to pleural effusions and they
were reclassified as T3M1a. This change was another
reason for increase in number of patients in T2 and T3
categories in TNM 7. When compared to the study
Table 2 TNM staging
TNM stage TNM 7 TNM 6
T1 3 3
T2 25 20
T3 11 5
T4 23 34
(T4 by pleural effusions-19)
M3 4
(pleural effusions M1a-19)
17
Table 3 Group staging according to each TNM system
Stage TNM 7 TNM 6
IA 2 2
IB 3 3
IIA 0 1
IIB 3 3
IIIA 9 9
IIIB 10 25
IV 35 19
Table 4 Management according to each TNM system
Management plan TNM 7 TNM 6
number % number %
surgical 17 27.5 18 29
non-surgical 45 72.5 44 71
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change in staging with TNM 7 was higher (32% Vs
25.1%) [8].
The most important finding in our study was the
number of patients in M category being doubled (34)
c o m p a r e dt ot h eo l dT N M6
th edition (17). This is due
to the reclassification of pleural effusion as M1a in
TNM7. In TNM 6 it was classified as T4. Due to the
same change the number of patients in Stage IV disease
in TNM 7 has increased and the number in stage IIIB
has decreased compared to TNM 6. Therefore the num-
ber of patients falling in to the category of “poor prog-
nosis” will be increased when TNM 7 is applied for
staging.
However when the two TNM systems were compared
there was only 1.5% reduction in the number of patients
undergoing surgery when TNM 7 was used compared
to TNM 6 which was not statistically significant. This is
because the patients with pleural effusions are consid-
ered inoperable in both the staging systems.
Conclusions
This study shows that a significant proportion of
patients with lung cancer were having advanced disease
with distant metastasis on presentation. The number of
patients falling to stage IV is significantly higher when
staged with TNM7 but there was no significant differ-
ence in the number of patients undergoing surgery
when TNM 7 was used compared to TNM6.
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Methods
The study was carried out in the Respiratory Unit of the
Teaching Hospital Kandy from 30
th April 2010 to 31
st
March 2011. The teaching hospital Kandy is the second
largest hospital in Sri Lanka and the respiratory unit is
the major referral center for chest diseases for nearly
one third of the island. The ethical clearance for the
study was granted by the ethical committee of the
Teaching Hospital Kandy. Written informed consent
was obtained from participants.
Patients referred to the Respiratory Unit with sus-
pected lung cancer were screened clinically and were
subjected to chest radiography. Those who had radio-
graphic features suggestive of lung cancer underwent
fiber optic bronchoscopy with bronchial biopsy, bron-
chial brushings and bronchial washings for cytology.
Those patients with lesions placed peripherally under-
went ultrasound guided or CT guided biopsy of the
lesions. Patients who had pleural effusions underwent
pleural biopsy and aspiration cytology in addition to
bronchoscopy. All those patients who were confirmed as
having lung cancer on histology were recruited to the
study and were staged according to TNM7 as well as
TNM6 for comparison. All patients underwent CT
thorax and upper abdomen which was the main tool
used for staging. Bronchoscopy was also used as a tool
for staging. Ultrasound abdomen and chest, × ray spine,
serum calcium, serum alkaline phosphatase, CT brain
and spine were used in some patients to detect second-
aries if they had clinical features of direct spread or dis-
semination to distant organs. TNM 7
th edition was used
to decide whether the patient should undergo surgical
or non-surgical management. Up to group stage IIIA
was considered as suitable for surgery and others were
considered for non-surgical management. The patients
were also staged using the TNM 6
th edition for
comparison.
Clinical data were collected using a symptom check
list and an interweaver administered questionnaire.
Investigation details such as bronchoscopy and CT find-
ings together with the clinical findings were entered into
a data sheet.
Data were analyzed for descriptive statistics using per-
centages, and the TNM 7
th edition was compared
against TNM 6
th edition using Chi-square statistics.
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